Evidence mapPaperPMID 40146377Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

The Association Between HbA1c Levels and the Risk of Myocardial Infarction and Stroke in People with Type 2 Diabetes: A Post Hoc Analysis of the REPRESENT Study.

Irene Cristina Romera, Jennifer Redondo-Antón, Miriam Rubio-de Santos, Silvia Díaz-Cerezo, Esther Artime, Albert Rafels-Ybern, Emilio Ortega, Ignacio Conget

Abstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Irene Cristina RomeraEli Lilly and Company, Avda. de la Industria 30, Alcobendas, 28108, Madrid, Spain. romera_irene@lilly.com.ORCID http://orcid.org/0000-0002-1345-9799
Jennifer Redondo-AntónEli Lilly and Company, Avda. de la Industria 30, Alcobendas, 28108, Madrid, Spain.ORCID http://orcid.org/0000-0003-2661-5866
Miriam Rubio-de SantosEli Lilly and Company, Avda. de la Industria 30, Alcobendas, 28108, Madrid, Spain.ORCID http://orcid.org/0000-0001-7393-6334
Silvia Díaz-CerezoEli Lilly and Company, Avda. de la Industria 30, Alcobendas, 28108, Madrid, Spain.ORCID http://orcid.org/0000-0001-6351-818X
Esther ArtimeEli Lilly and Company, Avda. de la Industria 30, Alcobendas, 28108, Madrid, Spain.ORCID http://orcid.org/0000-0003-4294-6462
Albert Rafels-YbernIQVIA HEOR-RWES, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1864-6155
Emilio OrtegaDiabetes Unit, Department of Endocrinology and Nutrition, Hospital Clínic, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2217-8905
Ignacio CongetDiabetes Unit, Department of Endocrinology and Nutrition, Hospital Clínic, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5532-5449

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this work was to analyze the association between baseline glycated hemoglobin (HbA1c) levels and other factors on the risk of first myocardial infarction (MI) and on the risk of first stroke in people with type 2 diabetes (T2D) in Spain.

methodsThis post hoc analysis of the REPRESENT study used the IQVIA electronic medical records database. Cumulative incidences were estimated using the Kaplan-Meier method, and Cox regression models were used to identify associated risk factors, including gender, age, HbA1c, or prior cardiovascular disease (other than MI/stroke).

resultsMedian follow-up was 7 years. In people without prior MI/stroke, the incidence (95% confidence interval [CI]) of first MI/stroke was 0.31 (0.28-0.34) and 0.18 (0.15-0.20) events per 100 patient-years, respectively. Baseline HbA1c levels < 6.5% were independently associated with lower risk of first MI (hazard ratio [HR] 0.76 [95% CI 0.61-0.94]) and of first stroke (HR 0.74 [95% CI 0.56-0.98]). Male sex, age ≥ 50 years, and previous cardiovascular disease were independently associated with a higher risk of MI/stroke.

conclusionsThis analysis found an association between baseline HbA1c levels < 6.5% and lower risk of a first MI or stroke in a T2D cohort in Spain, suggesting a role of stringent glycemic control in the prevention of cardiovascular complications.

Indexed as

Glycated hemoglobinMyocardial infarctionStrokeType 2 diabetes

Identifiers

PMID40146377
PMCPMC12085494

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.